Related Experiment Video

Updated: Jun 11, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

Cytokine-Based Validation of the Inflammation-Based Risk Score in Patients with ST-Segment Elevation Myocardial

Brianda Amezcua-Guerra1, Luis M Amezcua-Castillo2, Jazmín A Guerra-López3

  • 1School of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|October 2, 2024
PubMed

Insights

An inflammation risk score effectively predicts cytokine profiles, including elevated interleukin-6 and reduced interferon-γ-induced protein-10, in ST-segment elevation myocardial infarction (STEMI) patients. Higher scores correlate with adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Immunology
  • Biomarkers

Background:

  • Systemic inflammation plays a critical role in ST-segment elevation myocardial infarction (STEMI) pathogenesis.
  • Accurate assessment of inflammation is crucial for predicting patient outcomes.
  • Existing risk scores may not fully capture the inflammatory state in STEMI.

Purpose of the Study:

  • To validate an inflammation-based risk score using cytokine profiles in STEMI patients.
  • To investigate the association between the risk score and specific inflammatory biomarkers.
  • To determine if the risk score predicts major adverse cardiovascular events (MACE).

Main Methods:

  • Developed an inflammation risk score based on leukocyte count, high-sensitivity C-reactive protein (hsCRP), and serum albumin levels.
  • Categorized STEMI patients into no, mild, and severe inflammation groups.
  • Measured serum levels of 16 key cytokines, including IL-6 and IP-10, and analyzed their correlation with the risk score and clinical outcomes.

Main Results:

  • Higher inflammation risk scores were significantly associated with elevated Interleukin-6 (IL-6) and decreased Interferon-γ-induced protein-10 (IP-10) levels.
  • IL-6 showed positive correlation with hsCRP and negative correlation with albumin.
  • IP-10 demonstrated a negative correlation with leukocyte count.
  • The inflammation score was linked to an increased incidence of MACE, particularly acute heart failure.

Conclusions:

  • The inflammation-based risk score is a valid tool for assessing systemic inflammation in STEMI.
  • The score correlates with specific cytokine profiles (IL-6, IP-10) and predicts adverse cardiovascular events.
  • This score can aid in risk stratification and management of STEMI patients.

Keywords:
IP-10ST-segment elevation myocardial infarctioninflammationinterleukin-6

More Related Videos

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.1K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.2K

Related Concept Videos

Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and clinical manifestations

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
109
Acute Coronary SyndromeI: Introduction01:30

Acute Coronary SyndromeI: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
15